The Jackson Laboratory
Farmington, United States
Roel Verhaak, PhD., is a Professor and Associate Director of Computational Biology at the Jackson Laboratory for Genomic Medicine in Farmington, CT, where he holds the Florine Deschenes Roux Chair in Genetics and Genomics. He trained at the Erasmus Medical Center in the Netherlands and performed a postdoctoral fellowship at the Broad Institute and the Dana-Farber Cancer Institute in Boston, MA. After joining the faculty of MD Anderson Cancer Center in Houston, TX, in 2010, he moved to the Jackson Lab in 2016. The Verhaak lab studies glioma using genomic characterization and computational analyses, work that has helped redefine the way glioma in adult patients is classified. More recent efforts are focused on tumor evolution, which the lab is investigating using longitudinal tumor sequencing, single-cell sequencing, and functional perturbation approaches. The Verhaak lab has played a central role in the development of the Glioma Longitudinal Analysis (GLASS) Consortium. Roel Verhaak is a recipient of the AAAS Wachtel Award, the Agilent Early Career Professor Award, and the Peter Steck Memorial Award. He is a co-founder of Boundless Bio, a biotech company developing therapies against cancers containing extrachromosomal DNA amplifications.